Moderna sees 'positive' Phase I data for potential coronavirus vaccine
Published
Biotech company Moderna announced on Monday that its COVID-19 vaccine produced antibodies in all 45 participants in a trial, a significant milestone in the fight against the coronavirus pandemic.
Full Article